These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 5151119)

  • 41. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures.
    Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA
    Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rifampicin reduces plasma concentrations of moxifloxacin in patients with tuberculosis.
    Nijland HM; Ruslami R; Suroto AJ; Burger DM; Alisjahbana B; van Crevel R; Aarnoutse RE
    Clin Infect Dis; 2007 Oct; 45(8):1001-7. PubMed ID: 17879915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
    Dal Negro R; Turco P; Trevisan F; De Conti F
    Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis].
    Khomenko AG; Karachunskiĭ MA; Dorozhkova IR; Chukanov VI; Balta IuE
    Probl Tuberk; 1980 Feb; (2):18-23. PubMed ID: 6769110
    [No Abstract]   [Full Text] [Related]  

  • 45. [A long-term observation on previously treated cases of pulmonary tuberculosis retreated with rifampicin for more than six months (author's transl)].
    Tamura M; Takazawa N; Asada T; Ikegaki H; Yamada M; Kushiro S; Tada T
    Kekkaku; 1979 May; 54(5):285-95. PubMed ID: 113607
    [No Abstract]   [Full Text] [Related]  

  • 46. [Results of follow-up on advanced cases of pulmonary tuberculosis converted to negative with rifampicin treatment].
    Yamamoto M; Isoe K; Nakamura H; Hirose H; Izumi S
    Kekkaku; 1972 Nov; 47(11):393-7. PubMed ID: 4630902
    [No Abstract]   [Full Text] [Related]  

  • 47. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S; Caugant DA; Sandven P; Mariandyshev AO; Bjune G
    Int J Tuberc Lung Dis; 2002 May; 6(5):406-14. PubMed ID: 12019916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparative therapeutic activity of rifampicin and isoniazid in different densities of microbial population in the lungs of experimental animals].
    Sodikov ES; Ismatullaev F
    Probl Tuberk; 1986; (6):50-3. PubMed ID: 3092209
    [No Abstract]   [Full Text] [Related]  

  • 49. [The reactivation of pulmonary tuberculosis after effective chemotherapy using rifampicin].
    Roslik SM; Pashkov IuN; Matveeva SL; Gerasimova TG; Liudvichek IA; Iushchenko LP; Iakovleva LM; Stepanenko AL; Pankova LI
    Vrach Delo; 1990 Nov; (11):18-20. PubMed ID: 2098972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Contemporary methods in the diagnosis and treatment of intrathoracic tuberculosis in children].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Pogodaeva NP; Iavorskiĭ KM
    Probl Tuberk; 1994; (6):16-8. PubMed ID: 7708637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effective serum concentration of antimicrobial agents and intervals of bacteriological by negative tests in tuberculosis].
    Porven G; Rodríguez EJ; López JA; Piccolo R; Lmbertini A
    Rev Asoc Argent Microbiol; 1974; 6(3):110-8. PubMed ID: 4467223
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effectiveness of chemotherapy of chronic forms of pulmonary tuberculosis under hospital conditions].
    Kolesnikov VV; Mikhaĭlov VI; Matviiakina TS
    Probl Tuberk; 1980 Mar; (3):41-4. PubMed ID: 7393892
    [No Abstract]   [Full Text] [Related]  

  • 55. Drug-resistance tuberculosis among the foreign-born in Canada.
    Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449
    [No Abstract]   [Full Text] [Related]  

  • 56. The clearance of theophylline is increased during the initial period of tuberculosis treatment.
    Ahn HC; Lee YC
    Int J Tuberc Lung Dis; 2003 Jun; 7(6):587-91. PubMed ID: 12797703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
    Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
    Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of recent pulmonary tuberculosis with combined rifomycin-isoniazid].
    Constans P; Morin Y; Coury C; Bariety M
    Acta Tuberc Pneumol Belg; 1969; 60(3):545-53. PubMed ID: 5371679
    [No Abstract]   [Full Text] [Related]  

  • 60. [Rifampicine. 1st results in the treatment of pulmonary tuberculosis].
    Bernadou M; Chomy P; Fréour P; Bolinelli J; Wanou JJ
    Bord Med; 1970; 3(7):1855-60. PubMed ID: 5454997
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.